Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp1
|
ENSMUSG00000030067.11 | forkhead box P1 |
Foxj2
|
ENSMUSG00000003154.9 | forkhead box J2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_122825530_122825681 | Foxj2 | 1070 | 0.326811 | 0.26 | 4.3e-02 | Click! |
chr6_122825744_122826877 | Foxj2 | 365 | 0.749385 | 0.23 | 8.2e-02 | Click! |
chr6_122827831_122827982 | Foxj2 | 1231 | 0.279643 | 0.20 | 1.3e-01 | Click! |
chr6_122824213_122824868 | Foxj2 | 2135 | 0.164390 | 0.16 | 2.3e-01 | Click! |
chr6_122819948_122820699 | Foxj2 | 188 | 0.603507 | -0.11 | 4.2e-01 | Click! |
chr6_98999203_98999770 | Foxp1 | 4194 | 0.325136 | -0.67 | 4.4e-09 | Click! |
chr6_99430636_99430881 | Foxp1 | 4587 | 0.218577 | -0.63 | 5.6e-08 | Click! |
chr6_99101286_99102051 | Foxp1 | 5463 | 0.273775 | 0.62 | 1.6e-07 | Click! |
chr6_99095299_99096526 | Foxp1 | 293 | 0.931853 | 0.56 | 3.7e-06 | Click! |
chr6_99263243_99263544 | Foxp1 | 3122 | 0.369446 | 0.51 | 2.7e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_119673827_119675890 | 10.36 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr8_57320946_57324000 | 9.98 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chrX_143825863_143827628 | 9.61 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr5_43869783_43870400 | 7.70 |
Cd38 |
CD38 antigen |
1231 |
0.3 |
chr8_57324709_57326732 | 7.63 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr2_34873990_34875403 | 7.28 |
Cutal |
cutA divalent cation tolerance homolog-like |
178 |
0.6 |
chr5_119838900_119840891 | 7.01 |
Tbx5 |
T-box 5 |
3740 |
0.21 |
chr1_136945385_136947968 | 6.67 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr2_9882196_9886301 | 6.42 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr13_3891572_3893506 | 6.22 |
Net1 |
neuroepithelial cell transforming gene 1 |
894 |
0.46 |
chr10_5287995_5289689 | 6.07 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr3_65953043_65954518 | 5.98 |
Ccnl1 |
cyclin L1 |
787 |
0.49 |
chr10_69925300_69927130 | 5.80 |
Ank3 |
ankyrin 3, epithelial |
82 |
0.99 |
chr2_84423814_84425562 | 5.79 |
Calcrl |
calcitonin receptor-like |
578 |
0.75 |
chr5_75377467_75378104 | 5.66 |
Gm22084 |
predicted gene, 22084 |
5640 |
0.2 |
chr10_22815720_22817074 | 5.58 |
Gm10824 |
predicted gene 10824 |
648 |
0.66 |
chr18_11047852_11049020 | 5.56 |
Gata6os |
GATA binding protein 6, opposite strand |
799 |
0.66 |
chr4_41272272_41273407 | 5.44 |
Ubap2 |
ubiquitin-associated protein 2 |
2277 |
0.18 |
chr7_19290671_19291896 | 5.33 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr19_45445658_45446098 | 5.27 |
Btrc |
beta-transducin repeat containing protein |
370 |
0.86 |
chr18_65393136_65393441 | 5.25 |
Alpk2 |
alpha-kinase 2 |
606 |
0.6 |
chr9_101196473_101196755 | 5.25 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
2237 |
0.2 |
chr6_99204059_99205669 | 5.23 |
Foxp1 |
forkhead box P1 |
41846 |
0.2 |
chr4_115057577_115059724 | 5.10 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr1_156615340_156616247 | 5.07 |
Abl2 |
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
130 |
0.96 |
chr9_24769617_24771807 | 5.06 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chr10_120364470_120365452 | 4.99 |
1700006J14Rik |
RIKEN cDNA 1700006J14 gene |
748 |
0.63 |
chr12_72944998_72946304 | 4.95 |
Gm26709 |
predicted gene, 26709 |
156 |
0.94 |
chr10_13093078_13094452 | 4.90 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
2752 |
0.29 |
chr17_85485071_85487191 | 4.84 |
Rpl31-ps16 |
ribosomal protein L31, pseudogene 16 |
12502 |
0.23 |
chr13_89540278_89541317 | 4.81 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
1001 |
0.64 |
chr17_86329135_86330112 | 4.80 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
42445 |
0.19 |
chr1_163358681_163359585 | 4.80 |
Gm24940 |
predicted gene, 24940 |
43150 |
0.12 |
chr16_14706735_14707615 | 4.77 |
Snai2 |
snail family zinc finger 2 |
1323 |
0.53 |
chr9_111055888_111057545 | 4.75 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr12_32208046_32209200 | 4.72 |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
12 |
0.98 |
chr6_99095299_99096526 | 4.72 |
Foxp1 |
forkhead box P1 |
293 |
0.93 |
chr12_69757617_69759559 | 4.71 |
Mir681 |
microRNA 681 |
5356 |
0.14 |
chr9_50692780_50693781 | 4.70 |
Dixdc1 |
DIX domain containing 1 |
519 |
0.7 |
chr14_46385551_46387400 | 4.68 |
Bmp4 |
bone morphogenetic protein 4 |
829 |
0.41 |
chr13_73262153_73264451 | 4.59 |
Irx4 |
Iroquois homeobox 4 |
2805 |
0.22 |
chr2_158153509_158154452 | 4.58 |
Tgm2 |
transglutaminase 2, C polypeptide |
7544 |
0.16 |
chr13_31004637_31005089 | 4.56 |
Gm11371 |
predicted gene 11371 |
4314 |
0.21 |
chr8_109352498_109353726 | 4.56 |
Gm1943 |
predicted gene 1943 |
12248 |
0.24 |
chr6_119194389_119194967 | 4.48 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
1553 |
0.37 |
chr8_68205432_68207408 | 4.42 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
363 |
0.91 |
chr3_146047158_146048273 | 4.41 |
Wdr63 |
WD repeat domain 63 |
530 |
0.75 |
chr8_57335453_57336294 | 4.40 |
Gm34030 |
predicted gene, 34030 |
1288 |
0.34 |
chr3_137980299_137981827 | 4.39 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
467 |
0.74 |
chr17_43360343_43362046 | 4.37 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
743 |
0.75 |
chr6_72379584_72380121 | 4.33 |
Vamp5 |
vesicle-associated membrane protein 5 |
570 |
0.58 |
chrX_164374431_164375504 | 4.32 |
Vegfd |
vascular endothelial growth factor D |
1589 |
0.39 |
chr15_3580312_3581004 | 4.27 |
Ghr |
growth hormone receptor |
1184 |
0.57 |
chrX_52609355_52610313 | 4.27 |
Gpc3 |
glypican 3 |
4087 |
0.23 |
chrX_96456094_96457321 | 4.26 |
Heph |
hephaestin |
279 |
0.62 |
chr16_95456632_95459094 | 4.25 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr5_31251110_31252754 | 4.25 |
Krtcap3 |
keratinocyte associated protein 3 |
5 |
0.93 |
chr10_68135346_68136945 | 4.24 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
481 |
0.87 |
chr10_37139080_37141738 | 4.19 |
5930403N24Rik |
RIKEN cDNA 5930403N24 gene |
495 |
0.74 |
chr18_35739288_35740804 | 4.17 |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
30 |
0.95 |
chr3_36531782_36532903 | 4.11 |
Gm11549 |
predicted gene 11549 |
11 |
0.96 |
chr18_4993802_4994475 | 4.10 |
Svil |
supervillin |
325 |
0.94 |
chr2_84634714_84636973 | 4.09 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
2262 |
0.17 |
chr4_135727528_135728972 | 4.08 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
78 |
0.96 |
chr11_34845636_34846358 | 4.01 |
Gm22022 |
predicted gene, 22022 |
3643 |
0.22 |
chr6_135362982_135365483 | 4.00 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr9_92251154_92251727 | 3.99 |
Plscr1 |
phospholipid scramblase 1 |
1098 |
0.45 |
chr13_15466077_15468087 | 3.99 |
Gli3 |
GLI-Kruppel family member GLI3 |
3102 |
0.22 |
chr11_20635291_20636677 | 3.96 |
Sertad2 |
SERTA domain containing 2 |
4005 |
0.26 |
chr13_106835269_106836682 | 3.93 |
Lrrc70 |
leucine rich repeat containing 70 |
173 |
0.7 |
chr6_67161907_67162479 | 3.93 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
2731 |
0.23 |
chr5_74197172_74198949 | 3.90 |
Rasl11b |
RAS-like, family 11, member B |
169 |
0.94 |
chr2_20547166_20548761 | 3.88 |
Etl4 |
enhancer trap locus 4 |
17 |
0.99 |
chr14_120296391_120298017 | 3.87 |
Mbnl2 |
muscleblind like splicing factor 2 |
470 |
0.87 |
chr10_97566192_97567945 | 3.85 |
Lum |
lumican |
1940 |
0.32 |
chr3_146700203_146700695 | 3.83 |
Gm9480 |
predicted gene 9480 |
4230 |
0.17 |
chr16_92693730_92694957 | 3.80 |
Runx1 |
runt related transcription factor 1 |
1152 |
0.59 |
chr8_57331786_57332929 | 3.79 |
5033428I22Rik |
RIKEN cDNA 5033428I22 gene |
78 |
0.95 |
chr8_121174526_121175652 | 3.79 |
5033426O07Rik |
RIKEN cDNA 5033426O07 gene |
26746 |
0.13 |
chr6_51171741_51172819 | 3.77 |
Mir148a |
microRNA 148a |
97630 |
0.07 |
chr5_147304305_147307985 | 3.77 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr6_136857054_136858156 | 3.77 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr8_82400401_82400776 | 3.75 |
Il15 |
interleukin 15 |
1245 |
0.53 |
chr10_4335326_4335935 | 3.75 |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
1085 |
0.51 |
chr18_61663767_61665554 | 3.74 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
830 |
0.45 |
chr9_22134719_22135019 | 3.71 |
Acp5 |
acid phosphatase 5, tartrate resistant |
822 |
0.35 |
chr18_62174392_62175675 | 3.71 |
Adrb2 |
adrenergic receptor, beta 2 |
4926 |
0.21 |
chr1_183146101_183147201 | 3.70 |
Disp1 |
dispatched RND transporter family member 1 |
810 |
0.67 |
chr14_46491764_46491915 | 3.68 |
Gm34756 |
predicted gene, 34756 |
10611 |
0.12 |
chr9_120022870_120023448 | 3.68 |
Xirp1 |
xin actin-binding repeat containing 1 |
439 |
0.69 |
chr17_48430197_48430460 | 3.67 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
2290 |
0.18 |
chr1_51288641_51290950 | 3.64 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr7_133114831_133116529 | 3.64 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr4_124276838_124278353 | 3.61 |
Gm37667 |
predicted gene, 37667 |
1582 |
0.35 |
chr9_21337624_21338958 | 3.60 |
Slc44a2 |
solute carrier family 44, member 2 |
463 |
0.67 |
chr5_75975825_75977229 | 3.59 |
Kdr |
kinase insert domain protein receptor |
1931 |
0.31 |
chr10_53340367_53340889 | 3.57 |
Pln |
phospholamban |
2923 |
0.17 |
chr17_84180639_84182724 | 3.56 |
Gm36279 |
predicted gene, 36279 |
4075 |
0.18 |
chr16_12704768_12705585 | 3.56 |
Gm38619 |
predicted gene, 38619 |
808 |
0.73 |
chr1_12875347_12875986 | 3.56 |
Sulf1 |
sulfatase 1 |
32875 |
0.18 |
chr7_120979495_120980366 | 3.55 |
Cdr2 |
cerebellar degeneration-related 2 |
1860 |
0.19 |
chr4_83050960_83052655 | 3.55 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
360 |
0.89 |
chr5_52782719_52783830 | 3.54 |
Zcchc4 |
zinc finger, CCHC domain containing 4 |
152 |
0.96 |
chr3_89436767_89437632 | 3.54 |
Pbxip1 |
pre B cell leukemia transcription factor interacting protein 1 |
443 |
0.64 |
chr5_147752482_147753475 | 3.54 |
Gm43156 |
predicted gene 43156 |
7462 |
0.2 |
chr10_116177098_116178206 | 3.53 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
241 |
0.95 |
chr17_79451074_79451933 | 3.53 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
96412 |
0.07 |
chr13_22039834_22040858 | 3.52 |
H4c9 |
H4 clustered histone 9 |
1016 |
0.18 |
chr9_105520039_105521535 | 3.50 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr15_9073302_9073784 | 3.49 |
Nadk2 |
NAD kinase 2, mitochondrial |
1734 |
0.41 |
chr3_142496513_142497790 | 3.47 |
Gbp5 |
guanylate binding protein 5 |
209 |
0.93 |
chr7_71471596_71472579 | 3.46 |
Gm29328 |
predicted gene 29328 |
101754 |
0.07 |
chr15_25940423_25941291 | 3.46 |
Retreg1 |
reticulophagy regulator 1 |
30 |
0.98 |
chr14_67001080_67002197 | 3.45 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
1130 |
0.43 |
chr9_5308602_5309732 | 3.45 |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
302 |
0.91 |
chr8_33903951_33904228 | 3.45 |
Rbpms |
RNA binding protein gene with multiple splicing |
12325 |
0.17 |
chr19_45675708_45677086 | 3.45 |
Fbxw4 |
F-box and WD-40 domain protein 4 |
16085 |
0.17 |
chr3_106788400_106790067 | 3.45 |
Cd53 |
CD53 antigen |
916 |
0.58 |
chr1_43196103_43196958 | 3.44 |
Fhl2 |
four and a half LIM domains 2 |
231 |
0.93 |
chr10_69888271_69888587 | 3.44 |
Ank3 |
ankyrin 3, epithelial |
9702 |
0.31 |
chr10_68278824_68280301 | 3.42 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
822 |
0.67 |
chr8_33916300_33917561 | 3.42 |
Rbpms |
RNA binding protein gene with multiple splicing |
12346 |
0.17 |
chr11_85833878_85836704 | 3.42 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr6_34598108_34599085 | 3.42 |
Cald1 |
caldesmon 1 |
24 |
0.98 |
chr11_83849571_83850989 | 3.40 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr10_83153256_83154297 | 3.40 |
Gm23122 |
predicted gene, 23122 |
4351 |
0.24 |
chr18_75384437_75388058 | 3.40 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr1_121096624_121097922 | 3.39 |
Celrr |
cerebellum expressed regulatory RNA |
9744 |
0.27 |
chr7_104244475_104245215 | 3.38 |
Trim34a |
tripartite motif-containing 34A |
352 |
0.71 |
chr4_128805343_128806839 | 3.38 |
Zfp362 |
zinc finger protein 362 |
46 |
0.97 |
chr3_14888603_14889051 | 3.36 |
Car2 |
carbonic anhydrase 2 |
2188 |
0.31 |
chr10_18845717_18847414 | 3.36 |
Perp |
PERP, TP53 apoptosis effector |
1545 |
0.37 |
chr1_185515159_185516225 | 3.36 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
18304 |
0.17 |
chr5_102768473_102769767 | 3.36 |
Arhgap24 |
Rho GTPase activating protein 24 |
349 |
0.93 |
chr8_23035959_23037041 | 3.34 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr12_117657998_117660727 | 3.34 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr4_103120189_103120577 | 3.34 |
Mier1 |
MEIR1 treanscription regulator |
973 |
0.5 |
chr2_170153321_170154276 | 3.34 |
Zfp217 |
zinc finger protein 217 |
5695 |
0.31 |
chr16_57551520_57552150 | 3.32 |
Filip1l |
filamin A interacting protein 1-like |
2593 |
0.35 |
chr3_153908033_153909893 | 3.32 |
Snord45b |
small nucleolar RNA, C/D box 45B |
1670 |
0.17 |
chr11_76337532_76338135 | 3.31 |
Nxn |
nucleoredoxin |
61235 |
0.09 |
chr13_21917785_21919224 | 3.31 |
Gm44456 |
predicted gene, 44456 |
6512 |
0.07 |
chr7_73540370_73541687 | 3.29 |
Chd2 |
chromodomain helicase DNA binding protein 2 |
497 |
0.66 |
chr11_18873955_18876215 | 3.29 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
776 |
0.61 |
chr12_34713492_34714861 | 3.29 |
Gm47357 |
predicted gene, 47357 |
85538 |
0.09 |
chr19_40812757_40814183 | 3.29 |
Ccnj |
cyclin J |
17809 |
0.16 |
chr4_12655171_12655830 | 3.29 |
Gm37985 |
predicted gene, 37985 |
58112 |
0.16 |
chr3_60504423_60505028 | 3.28 |
Mbnl1 |
muscleblind like splicing factor 1 |
3447 |
0.29 |
chr4_135203004_135203155 | 3.28 |
Runx3 |
runt related transcription factor 3 |
48643 |
0.1 |
chr1_71650941_71652042 | 3.27 |
Apol7d |
apolipoprotein L 7d |
1346 |
0.36 |
chr6_21822751_21823961 | 3.22 |
Tspan12 |
tetraspanin 12 |
28472 |
0.16 |
chr4_102568544_102569595 | 3.21 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1026 |
0.69 |
chr12_51348323_51349618 | 3.21 |
G2e3 |
G2/M-phase specific E3 ubiquitin ligase |
598 |
0.78 |
chr12_9580218_9581715 | 3.21 |
Osr1 |
odd-skipped related transcription factor 1 |
6525 |
0.19 |
chr2_69670826_69672050 | 3.20 |
Klhl41 |
kelch-like 41 |
1318 |
0.37 |
chr13_23500820_23501422 | 3.19 |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
12264 |
0.06 |
chr2_164438272_164438997 | 3.19 |
Sdc4 |
syndecan 4 |
4552 |
0.1 |
chr6_134916293_134917599 | 3.19 |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
3455 |
0.13 |
chr3_61004705_61005734 | 3.18 |
Gm37035 |
predicted gene, 37035 |
1433 |
0.42 |
chr2_115579096_115580156 | 3.18 |
Gm13977 |
predicted gene 13977 |
1929 |
0.3 |
chr2_35334268_35334953 | 3.17 |
Stom |
stomatin |
2366 |
0.21 |
chr10_121016694_121017069 | 3.17 |
Gm48341 |
predicted gene, 48341 |
15820 |
0.14 |
chr14_41007005_41008239 | 3.16 |
Prxl2a |
peroxiredoxin like 2A |
644 |
0.68 |
chr18_37694128_37695315 | 3.16 |
Pcdhga5 |
protocadherin gamma subfamily A, 5 |
341 |
0.59 |
chr16_56477860_56479061 | 3.15 |
Abi3bp |
ABI gene family, member 3 (NESH) binding protein |
560 |
0.85 |
chr8_23043503_23044627 | 3.15 |
Ank1 |
ankyrin 1, erythroid |
8834 |
0.18 |
chr1_184729496_184731200 | 3.14 |
Hlx |
H2.0-like homeobox |
1250 |
0.37 |
chr6_35256935_35257368 | 3.13 |
1810058I24Rik |
RIKEN cDNA 1810058I24 gene |
4419 |
0.17 |
chr10_103000985_103001486 | 3.13 |
Alx1 |
ALX homeobox 1 |
21339 |
0.19 |
chr7_100465236_100467118 | 3.13 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr5_52254526_52255173 | 3.12 |
Gm43180 |
predicted gene 43180 |
15513 |
0.15 |
chr6_120819964_120820819 | 3.12 |
Atp6v1e1 |
ATPase, H+ transporting, lysosomal V1 subunit E1 |
1992 |
0.25 |
chr9_70847519_70848229 | 3.12 |
Gm3436 |
predicted pseudogene 3436 |
4702 |
0.24 |
chr8_47750060_47750343 | 3.12 |
Gm31786 |
predicted gene, 31786 |
67 |
0.95 |
chr3_142442968_142443774 | 3.11 |
Pdlim5 |
PDZ and LIM domain 5 |
47675 |
0.12 |
chrX_85613609_85614890 | 3.10 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chr16_85549016_85550538 | 3.10 |
Cyyr1 |
cysteine and tyrosine-rich protein 1 |
640 |
0.75 |
chr18_32557788_32558922 | 3.08 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr1_181234123_181235106 | 3.08 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
7706 |
0.14 |
chr11_101163770_101165734 | 3.07 |
Plekhh3 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
572 |
0.52 |
chr7_75612178_75613652 | 3.07 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr14_63238426_63238958 | 3.07 |
Gata4 |
GATA binding protein 4 |
6556 |
0.18 |
chr16_16214897_16215480 | 3.07 |
Pkp2 |
plakophilin 2 |
1870 |
0.35 |
chr2_64097060_64097986 | 3.05 |
Fign |
fidgetin |
465 |
0.9 |
chr6_116650655_116651088 | 3.04 |
Depp1 |
DEPP1 autophagy regulator |
175 |
0.9 |
chr5_4023878_4025023 | 3.04 |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
1035 |
0.54 |
chr10_23894263_23895356 | 3.04 |
Vnn1 |
vanin 1 |
45 |
0.96 |
chr7_45599282_45599577 | 3.03 |
Gm31479 |
predicted gene, 31479 |
2289 |
0.1 |
chr1_130547972_130548539 | 3.03 |
Gm23623 |
predicted gene, 23623 |
47421 |
0.09 |
chr7_6694119_6695702 | 3.03 |
Zim1 |
zinc finger, imprinted 1 |
1519 |
0.27 |
chr10_97481185_97481829 | 3.03 |
Dcn |
decorin |
860 |
0.67 |
chr1_23271255_23272383 | 3.02 |
Mir30a |
microRNA 30a |
450 |
0.73 |
chr2_92140355_92141595 | 3.01 |
Phf21a |
PHD finger protein 21A |
43131 |
0.11 |
chr17_72921491_72924008 | 3.01 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr10_128084916_128086493 | 3.01 |
Atp5b |
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit |
42 |
0.75 |
chr3_96332970_96334964 | 3.01 |
Gm24830 |
predicted gene, 24830 |
5542 |
0.07 |
chr1_150991848_150992682 | 3.00 |
Hmcn1 |
hemicentin 1 |
786 |
0.64 |
chr16_33832675_33833646 | 2.99 |
Itgb5 |
integrin beta 5 |
3483 |
0.21 |
chr8_121088119_121090419 | 2.99 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr11_35024565_35025036 | 2.98 |
Slit3 |
slit guidance ligand 3 |
96424 |
0.08 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 20.9 | GO:0003166 | bundle of His development(GO:0003166) |
3.3 | 10.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
3.1 | 9.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.0 | 8.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.6 | 12.8 | GO:0003175 | tricuspid valve development(GO:0003175) |
2.5 | 7.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.3 | 6.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.3 | 2.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.3 | 6.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
2.2 | 2.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.1 | 8.5 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
2.1 | 4.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.8 | 8.8 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.7 | 5.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.7 | 5.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.7 | 5.0 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.6 | 4.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.6 | 4.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.6 | 4.8 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
1.4 | 5.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.4 | 4.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.4 | 5.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.3 | 4.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.3 | 9.2 | GO:0060613 | fat pad development(GO:0060613) |
1.3 | 11.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
1.3 | 1.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.3 | 3.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.3 | 3.8 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.3 | 6.4 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.3 | 5.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.2 | 4.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.2 | 1.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.1 | 3.4 | GO:0007525 | somatic muscle development(GO:0007525) |
1.1 | 4.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.1 | 3.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.1 | 3.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.1 | 4.4 | GO:0032264 | IMP salvage(GO:0032264) |
1.1 | 3.3 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.1 | 5.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.0 | 3.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.0 | 2.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.0 | 4.1 | GO:0050904 | diapedesis(GO:0050904) |
1.0 | 3.1 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.0 | 3.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.0 | 3.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.0 | 5.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.0 | 2.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 4.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.0 | 1.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.0 | 1.0 | GO:0061323 | cell proliferation involved in heart morphogenesis(GO:0061323) |
1.0 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 3.7 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.9 | 2.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.9 | 2.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.9 | 3.6 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.9 | 0.9 | GO:0070384 | Harderian gland development(GO:0070384) |
0.9 | 0.9 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.9 | 2.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.9 | 8.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.9 | 0.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.9 | 3.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.9 | 7.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.9 | 3.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.9 | 2.6 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.9 | 2.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.9 | 0.9 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.9 | 2.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.9 | 2.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.9 | 2.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.9 | 2.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.8 | 2.5 | GO:0035483 | gastric emptying(GO:0035483) |
0.8 | 6.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 4.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.8 | 4.9 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.8 | 3.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.8 | 2.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.8 | 6.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 3.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 4.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.8 | 1.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.8 | 1.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 2.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.8 | 2.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 1.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.8 | 3.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.8 | 1.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.7 | 2.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.7 | 1.5 | GO:0060157 | urinary bladder development(GO:0060157) |
0.7 | 3.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.7 | 3.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 3.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.7 | 2.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.7 | 2.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 3.6 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 4.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 2.9 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.7 | 2.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.7 | 2.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.7 | 1.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.7 | 3.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.7 | 0.7 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.7 | 0.7 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.7 | 3.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 0.7 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.7 | 2.1 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 2.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.7 | 1.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.7 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.7 | 1.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 2.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.7 | 2.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 2.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 3.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.7 | 2.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 2.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 2.0 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.7 | 2.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 2.7 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.7 | 2.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.7 | 1.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.7 | 0.7 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.7 | 2.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 0.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.7 | 2.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 2.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.7 | 4.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 1.3 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.6 | 4.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.6 | 2.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 0.6 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.6 | 1.9 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 1.9 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 1.3 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.6 | 2.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 7.7 | GO:0010226 | response to lithium ion(GO:0010226) |
0.6 | 3.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.6 | 1.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.6 | 2.5 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.6 | 1.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 1.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 0.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.6 | 3.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 1.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 1.2 | GO:0007494 | midgut development(GO:0007494) |
0.6 | 1.8 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.6 | 2.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.6 | 1.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 2.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 0.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.6 | 0.6 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.6 | 2.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.6 | 3.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 2.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 4.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.6 | 1.2 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.6 | 4.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 0.6 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.6 | 5.7 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.6 | 2.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 2.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 1.7 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.6 | 1.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.6 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.6 | 2.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 2.2 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.5 | 2.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 2.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 0.5 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.5 | 1.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.5 | 3.8 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.5 | 2.7 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.5 | 0.5 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.5 | 3.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 2.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 2.6 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.5 | 0.5 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.5 | 0.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 4.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 2.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.5 | 0.5 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 1.0 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 2.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.5 | 2.0 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.5 | 4.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 2.0 | GO:0033504 | floor plate development(GO:0033504) |
0.5 | 2.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 1.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 2.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 1.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.5 | 1.0 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.5 | 1.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.5 | 1.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 4.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 1.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.5 | 2.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.5 | 5.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 1.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 2.0 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.5 | 2.4 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.5 | 3.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 1.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 1.9 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.5 | 1.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 1.0 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 3.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.5 | 1.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.5 | 1.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.5 | 0.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.5 | 1.0 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.5 | 1.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 3.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.5 | 0.5 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 2.8 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.5 | 1.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 1.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 1.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.5 | 0.5 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 0.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 0.5 | GO:0060435 | bronchiole development(GO:0060435) |
0.5 | 0.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 0.9 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 1.9 | GO:0007567 | parturition(GO:0007567) |
0.5 | 1.4 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.5 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 3.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 3.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 1.8 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 3.2 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.5 | 0.9 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.5 | 0.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.5 | 1.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 1.4 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.5 | 2.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 3.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 1.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 4.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 0.9 | GO:0006188 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 1.3 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.4 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.4 | 4.8 | GO:0051383 | kinetochore organization(GO:0051383) |
0.4 | 1.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.4 | 0.4 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 2.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 0.4 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.4 | 0.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 0.4 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.4 | 2.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 1.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 4.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.4 | 0.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.4 | 1.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.4 | 0.4 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.4 | 3.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.4 | 0.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 1.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 3.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 1.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 3.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 0.4 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.4 | 2.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.4 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 1.7 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 1.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.4 | 4.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.4 | 2.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 3.3 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.4 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 1.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 2.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 3.2 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 1.6 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.4 | 0.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 0.4 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.4 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 1.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 1.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.4 | 7.0 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 1.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 0.4 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.4 | 1.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 1.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 1.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 2.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.4 | 3.1 | GO:0007379 | segment specification(GO:0007379) |
0.4 | 8.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 3.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 1.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 1.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.4 | 1.9 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.4 | 1.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 1.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.4 | 4.5 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.4 | 1.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.4 | 5.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.4 | 1.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 2.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 0.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.4 | 0.4 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.4 | 1.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.4 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 0.7 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.4 | 0.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 1.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 4.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 0.7 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.4 | 1.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 3.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 2.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 2.5 | GO:0043373 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.4 | 2.5 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.4 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 1.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 1.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.4 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.4 | 1.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.4 | 2.8 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.4 | 1.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 1.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.4 | 2.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 2.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 0.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.0 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 4.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 1.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 1.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 1.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 3.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 1.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 4.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 1.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 0.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.3 | GO:0009127 | purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
0.3 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 1.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.7 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.3 | 1.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.3 | 1.0 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 1.0 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.3 | 1.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 2.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.3 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.3 | 1.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 1.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 1.3 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 4.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 0.6 | GO:0014022 | neural plate morphogenesis(GO:0001839) neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 1.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 0.3 | GO:0052150 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.3 | 1.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 5.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 1.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 0.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 1.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 1.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 0.6 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.3 | 1.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 3.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 1.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 2.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.3 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.3 | 2.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.3 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 1.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.3 | 0.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.3 | 0.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 6.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.5 | GO:0030168 | platelet activation(GO:0030168) |
0.3 | 0.9 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 1.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.3 | 0.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.9 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 0.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 0.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.3 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 1.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.3 | 0.6 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 0.3 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.3 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 0.6 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 0.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.9 | GO:0015669 | gas transport(GO:0015669) |
0.3 | 0.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.3 | 0.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.3 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 0.3 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.3 | 1.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 5.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 0.9 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.3 | 0.6 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 0.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 2.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 5.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.3 | 0.6 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 0.6 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.3 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 1.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 1.7 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 1.7 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 0.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.8 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.3 | 0.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.3 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 2.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 1.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.3 | 0.8 | GO:0036394 | amylase secretion(GO:0036394) |
0.3 | 0.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.3 | 5.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 0.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 6.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 2.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 0.8 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.3 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.5 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 0.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 1.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 0.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.5 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 0.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 0.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.3 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 2.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 0.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 4.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 2.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 4.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 2.5 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.3 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 1.2 | GO:1902166 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 1.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 2.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 4.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.7 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 1.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 2.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 1.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.2 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 4.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 1.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 2.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 0.2 | GO:0072141 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.2 | 1.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.5 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.2 | 1.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.2 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 1.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.5 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.2 | 0.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 0.9 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.9 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.7 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 3.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.9 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.2 | 5.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.7 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 1.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.9 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.2 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 0.4 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.2 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 2.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 2.8 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 2.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 3.6 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.4 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 1.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.4 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.2 | 0.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.8 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 2.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.4 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 0.8 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.6 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 1.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 4.8 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.2 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 0.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 2.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.8 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 1.6 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 2.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.2 | 0.4 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 2.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.6 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.4 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.2 | 0.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 1.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 2.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.2 | 0.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.8 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 1.9 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 1.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.2 | GO:1901068 | GTP metabolic process(GO:0046039) guanosine-containing compound metabolic process(GO:1901068) |
0.2 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.2 | 1.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 1.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 2.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.7 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.2 | 0.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.2 | 0.9 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 1.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.4 | GO:2000870 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
0.2 | 0.4 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) |
0.2 | 2.0 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.2 | 2.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 0.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 3.1 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.2 | 0.5 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 2.9 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 2.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.2 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.2 | 4.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 2.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 1.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.3 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 1.5 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 1.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 1.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.2 | 0.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 1.5 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 1.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.3 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.2 | 0.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 5.3 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.5 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.2 | 2.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 1.5 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.3 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 1.3 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 0.7 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.2 | 0.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 0.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.5 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 1.0 | GO:0071265 | methionine biosynthetic process(GO:0009086) amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 1.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 1.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.5 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 1.4 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.2 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 1.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 1.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 2.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.2 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 1.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 5.3 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 2.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.6 | GO:0042559 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) |
0.2 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.4 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.1 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 1.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 1.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 1.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 1.0 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 1.2 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.7 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 3.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 2.6 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 3.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.4 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.1 | 1.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 1.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.1 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 1.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.1 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.8 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 1.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.3 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.6 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.7 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 2.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 2.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.1 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 4.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.7 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.4 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 2.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 2.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.8 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 2.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.3 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.1 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.1 | 0.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) |
0.1 | 0.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 0.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 1.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 6.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 3.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.5 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.7 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 1.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.5 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 4.0 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 2.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.7 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 5.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.2 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 0.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.4 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.9 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 1.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.5 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.5 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 2.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 1.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 3.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.1 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.1 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.7 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.4 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.8 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.3 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.5 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 2.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.7 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 1.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.1 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 1.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 3.6 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.1 | 0.2 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 2.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 1.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 2.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.9 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 1.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 1.1 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.7 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 1.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 2.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 1.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.7 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.3 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.3 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.0 | GO:0052696 | flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.2 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 1.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.7 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 1.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 1.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.2 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.3 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 5.6 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.1 | 0.3 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.1 | 0.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 1.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 1.5 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 2.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.0 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.1 | 0.2 | GO:0048304 | regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.3 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 1.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 2.3 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.2 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.1 | 0.2 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.4 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 1.2 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.7 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 1.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.4 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.4 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.4 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 1.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.1 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.5 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 1.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 1.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 1.9 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.4 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.1 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 1.0 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 2.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 1.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.3 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.0 | 0.1 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.8 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.0 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 1.3 | GO:0043038 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.0 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.0 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.6 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.0 | 0.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 1.4 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.3 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.5 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 3.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.1 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.0 | 0.1 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.0 | 0.0 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 2.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.3 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.1 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 1.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.0 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.0 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 1.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.6 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.0 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.0 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 1.5 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 0.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.0 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.0 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.0 | 0.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 12.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.8 | 5.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.5 | 1.5 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.3 | 1.3 | GO:1990423 | RZZ complex(GO:1990423) |
1.2 | 5.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.1 | 4.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 1.1 | GO:0070552 | BRISC complex(GO:0070552) |
1.0 | 4.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 3.9 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 3.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.9 | 6.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 3.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.8 | 2.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 3.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 2.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 3.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 2.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 1.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 3.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 2.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 2.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 5.3 | GO:0005861 | troponin complex(GO:0005861) |
0.7 | 5.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.6 | 3.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 4.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 3.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.6 | 2.4 | GO:0098536 | deuterosome(GO:0098536) |
0.6 | 9.7 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.6 | 4.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 5.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.6 | 1.8 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 2.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 0.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.5 | 2.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 3.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 1.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 1.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 1.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.3 | GO:0005712 | chiasma(GO:0005712) |
0.4 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 1.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 4.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 0.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 2.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 1.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 4.5 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 2.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.4 | 4.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.6 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 1.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 1.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 1.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 1.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 1.9 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 1.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 2.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 4.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 2.4 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 1.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 18.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 6.4 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 0.9 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 4.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 0.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 0.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 1.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 11.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 1.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 4.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 4.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 34.0 | GO:0044449 | contractile fiber part(GO:0044449) |
0.3 | 1.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 1.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 3.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 3.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 0.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 1.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 2.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 1.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 1.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 19.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 5.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 1.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 6.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 7.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 3.0 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.4 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 12.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 2.5 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 2.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 16.3 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 2.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 7.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 10.5 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 3.0 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 6.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 4.6 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 6.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 2.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 11.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 5.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 4.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 8.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.9 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 5.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 2.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 2.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 6.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 6.5 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 1.9 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 2.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 3.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 5.0 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 3.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.5 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 2.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 4.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 1.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 2.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 23.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
0.1 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 4.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 4.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.7 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 1.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.1 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 4.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.9 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 3.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 4.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 5.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 4.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.5 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 6.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 20.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 2.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 11.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 5.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 2.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 9.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 1.2 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 4.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 58.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 2.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 3.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 13.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.9 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.0 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.0 | 0.0 | GO:0036452 | ESCRT complex(GO:0036452) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 8.2 | GO:0031433 | telethonin binding(GO:0031433) |
2.0 | 5.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.8 | 5.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.8 | 3.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.6 | 4.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.6 | 4.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.5 | 4.5 | GO:0070538 | oleic acid binding(GO:0070538) |
1.5 | 4.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.4 | 8.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.3 | 3.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 3.8 | GO:0004064 | arylesterase activity(GO:0004064) |
1.3 | 7.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.2 | 6.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.2 | 3.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.1 | 5.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 4.5 | GO:0043515 | kinetochore binding(GO:0043515) |
1.0 | 5.1 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 3.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.9 | 2.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.9 | 2.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.9 | 2.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 2.5 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.8 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.8 | 2.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 2.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 3.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.8 | 4.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.8 | 3.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 2.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 2.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.7 | 6.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.7 | 2.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.7 | 3.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.7 | 2.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 4.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 2.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 2.5 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 2.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 6.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 2.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.6 | 1.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 2.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.6 | 1.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 4.0 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 2.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 4.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 1.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 1.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 2.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 1.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 1.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 0.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.5 | 1.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 1.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 2.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 3.0 | GO:0018500 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.5 | 1.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 2.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 1.5 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 1.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 3.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 3.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 1.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 3.0 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 1.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 4.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 2.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.5 | 2.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 17.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 1.9 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 2.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 4.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 0.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.5 | 1.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 5.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 2.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 1.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 5.7 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 7.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 1.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 1.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 2.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 1.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 5.2 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 1.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 1.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 1.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 3.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 2.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 1.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 5.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.5 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 1.5 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.4 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 2.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 2.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 3.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 5.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 2.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 24.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 7.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 1.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 3.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 3.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 5.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 13.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 5.1 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 3.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 1.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 2.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 3.4 | GO:0060229 | lipase activator activity(GO:0060229) |
0.3 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 6.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 7.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 1.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 2.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 2.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 16.5 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 2.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 1.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 1.5 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 3.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 0.3 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.3 | 26.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 1.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 5.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 3.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 3.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 0.9 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 0.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.7 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 0.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 5.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 2.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 1.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 1.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 2.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 0.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 2.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 3.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 1.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 2.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 2.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 1.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 1.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 1.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.9 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 2.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 3.5 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 2.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 2.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 2.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 1.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 1.4 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 2.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 2.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 3.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 2.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.9 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 0.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 4.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 7.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 2.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.0 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 4.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 2.5 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.2 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 10.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 12.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 2.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 6.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 5.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 1.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 1.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 13.1 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 1.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 3.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.3 | GO:0018634 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 1.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.9 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 1.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 4.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 4.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 11.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 1.6 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 5.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 4.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 5.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 2.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 2.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 8.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 2.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 1.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.6 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 1.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 3.5 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.6 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 0.3 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.1 | GO:0032557 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 5.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.7 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 5.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 3.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 3.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.6 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 2.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 2.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 3.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.5 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.5 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 1.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 11.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.8 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 3.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 5.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 1.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.1 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.1 | 1.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.2 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 2.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.8 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 7.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.3 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 5.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 1.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 6.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 6.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 2.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 1.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 12.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 4.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.6 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 2.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 3.3 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.4 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 2.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 1.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 5.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.7 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 4.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 1.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.2 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.4 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 3.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 4.5 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 1.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 4.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 2.1 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.0 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.5 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.0 | 0.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 2.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 19.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 10.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 21.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 14.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 5.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 6.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 20.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 20.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 1.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 11.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 2.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 3.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 2.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 22.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 4.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 8.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 4.1 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 1.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 2.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 10.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 9.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 4.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 6.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 2.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 5.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 1.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 11.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 5.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 3.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 2.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 5.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 2.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 8.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 3.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 9.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 4.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 5.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 2.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 1.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 9.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 8.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 4.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 5.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 10.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 7.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 0.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.0 | PID ATM PATHWAY | ATM pathway |
0.2 | 1.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 4.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 2.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 2.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.8 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 6.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 2.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 3.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 4.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 8.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 11.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 15.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 10.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 10.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 8.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 15.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 8.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 5.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 7.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 5.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 12.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 10.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 5.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.5 | 4.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 9.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 3.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 7.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 3.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 9.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 9.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 2.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 8.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 4.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 1.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 6.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 4.2 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.4 | 2.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 15.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 8.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.4 | 0.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 0.3 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.3 | 3.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 5.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 9.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 3.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 23.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 2.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 23.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 3.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 11.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 3.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 7.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 1.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 2.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 6.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 1.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 2.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 3.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 2.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 2.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 1.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 2.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 3.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 1.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 2.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 3.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 2.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 2.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 5.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 5.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 16.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.2 | 3.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 3.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 3.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 5.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 3.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 3.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 5.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 4.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 5.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 7.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 4.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 7.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 3.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 8.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 4.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 3.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 2.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 2.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 10.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 3.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 1.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 11.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 5.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 4.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 2.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 5.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.7 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 4.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 4.6 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.2 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.1 | 1.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.2 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 2.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 4.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 4.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 1.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 1.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.3 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.8 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |